Microba Life Sciences Statistics

Total Valuation

Microba Life Sciences has a market cap or net worth of AUD 87.33 million. The enterprise value is 67.82 million.

Market Cap	87.33M
Enterprise Value	67.82M

Important Dates

The next estimated earnings date is Tuesday, January 28, 2025.

Earnings Date	Jan 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Microba Life Sciences has 447.85 million shares outstanding. The number of shares has increased by 30.42% in one year.

Current Share Class	n/a
Shares Outstanding	447.85M
Shares Change (YoY)	+30.42%
Shares Change (QoQ)	+20.19%
Owned by Insiders (%)	18.79%
Owned by Institutions (%)	22.61%
Float	182.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.61
PB Ratio	2.12
P/TBV Ratio	3.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.40
EV / Sales	5.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.98

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.04.

Current Ratio	2.61
Quick Ratio	2.36
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	-373.26

Financial Efficiency

Return on equity (ROE) is -49.98% and return on invested capital (ROIC) is -39.14%.

Return on Equity (ROE)	-49.98%
Return on Assets (ROA)	-30.76%
Return on Capital (ROIC)	-39.14%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.23
Inventory Turnover	4.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.41%
50-Day Moving Average	0.17
200-Day Moving Average	0.18
Relative Strength Index (RSI)	63.64
Average Volume (20 Days)	116,257

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microba Life Sciences had revenue of AUD 12.09 million and -19.94 million in losses. Loss per share was -0.05.

Revenue	12.09M
Gross Profit	5.91M
Operating Income	-25.84M
Pretax Income	-19.99M
Net Income	-19.94M
EBITDA	-24.61M
EBIT	-25.84M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 21.09 million in cash and 1.58 million in debt, giving a net cash position of 19.51 million or 0.04 per share.

Cash & Cash Equivalents	21.09M
Total Debt	1.58M
Net Cash	19.51M
Net Cash Per Share	0.04
Equity (Book Value)	41.22M
Book Value Per Share	0.09
Working Capital	19.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.57 million and capital expenditures -1.49 million, giving a free cash flow of -17.05 million.

Operating Cash Flow	-15.57M
Capital Expenditures	-1.49M
Free Cash Flow	-17.05M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 48.85%, with operating and profit margins of -213.71% and -164.92%.

Gross Margin	48.85%
Operating Margin	-213.71%
Pretax Margin	-165.34%
Profit Margin	-164.92%
EBITDA Margin	-203.56%
EBIT Margin	-213.71%
FCF Margin	n/a

Dividends & Yields

Microba Life Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.42%
Shareholder Yield	-30.42%
Earnings Yield	-24.95%
FCF Yield	-19.53%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Microba Life Sciences has an Altman Z-Score of 0.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.99
Piotroski F-Score	n/a